Target intelligence / Profile preview

Histone H3.3 (family member 3B) (H3-3B)

Target
H3-3B
Molecular classification
Histone, Chromatin/nucleosome core protein, Epigenetic regulator
01

Overview

Histone H3.3 (family member 3B), encoded by the H3F3B gene, is a highly conserved histone variant involved in the formation of nucleosomes, the fundamental units of chromatin in eukaryotic cells[1][3]. Unlike canonical histone H3 (e.g., H3.1, H3.2), H3.3 is incorporated into chromatin independently of DNA replication and throughout the cell cycle by specialized histone chaperones (notably HIRA and DAXX complexes)[1][4]. H3.3 is found at actively transcribed regions, regulatory elements, and also in certain types of heterochromatin, participating in the dynamic regulation of gene expression, epigenetic memory, DNA repair, and chromosomal stability[1][2][4]. Mutations in H3-3B and its paralog H3F3A are implicated in various cancers (as driver mutations) and some neurodevelopmental syndromes[2][3][4]. No direct drugs target histone H3.3 clinically due to its fundamental role in chromatin integrity and cellular homeostasis.

Other names
H3.3 histone BHistone H3.3H3-3AH3.3AH3F3H3F3AH3.3BH3F3BPP781BRYLIB2H3 histone family member 3BH3 histone, family 3B (H3.3B)
02

Mechanism of action

not applicable (no drugs listed); in cancer, disease often results from gain- or loss-of-function mutations affecting chromatin states rather than direct pharmacological modulation[4]

03

Biological functions

DNA packaging (nucleosome assembly)Regulation of chromatin structureRegulation of transcriptionEpigenetic memory and modificationsDNA repairDNA replicationMaintenance of chromosomal stability
04

Disease associations

Cancer (including pediatric high-grade glioma and bone tumors via H3F3A/B mutations)Neurodevelopmental disorders (e.g., Bryant-Li-Bhoj Neurodevelopmental Syndrome)Age-related/neurodegenerative processes
05

Safety considerations

Direct targeting of histones is challenging due to their essential and ubiquitous role; modifying chromatin globally carries high risk of off-target effects and cellular toxicity
06

Biomarkers

Mutations in H3F3B (gene encoding H3-3B) as diagnostic/prognostic markers in pediatric tumors[2][4]

Beyond the preview

Go deeper on Histone H3.3 (family member 3B) (H3-3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H3.3 (family member 3B) (H3-3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call